Fig. 5: Tumors with high CD8+FOXP3−/FOXP3+ ratio show upregulation of ECM-integrin interaction pathways in our UUS cohort. | npj Precision Oncology

Fig. 5: Tumors with high CD8+FOXP3−/FOXP3+ ratio show upregulation of ECM-integrin interaction pathways in our UUS cohort.

From: FOXP3+ T cells in uterine sarcomas are associated with favorable prognosis, low extracellular matrix expression and reduced YAP activation

Fig. 5

a Metascape pathway analysis reveals the most significantly altered pathways in the CFRHigh group (CD8+FOXP3−/FOXP3+ >1) and their interactions. b MCODE-identified neighborhoods of densely connected proteins based on upregulated genes in the high CFR group showing their corresponding enriched Gene Ontologies. c Heat map of gene expression of significantly altered genes in the CFR-defined groups with patient clustering indicating their corresponding ECM signature as defined by Binzer-Panchal et al. d Ingenuity pathway analysis (IPA) indicates the potential upstream regulators of the differential gene expression between CFR high and low tumors. e Connectivity Map analysis shows potential gene expression-altering drugs for the upregulated genes in the CFRHigh compared to CFRLow groups. f Expression of 22 YAP-TEAD target genes in CFR groups and Low TILs. Significance is indicated as *(P < 0.05), **(P < 0.01), ***(P < 0.001).

Back to article page